Anti-CD40 Treatment of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-Exposed C57Bl/6 Mice Induces Activation of Antigen Presenting Cells Yet Fails to Overcome TCDD-Induced Suppression of Allograft Immunity

By Shepherd D.M.   Steppan L.B.   Hedstrom O.R.   Kerkvliet N.I.  

Toxicology and Applied Pharmacology, Vol. 170, Iss. 1, 2001-01 ,pp. : 10-22

Elsevier

Access to resources Recommend Favorite

Effects of CYP1A2 on Disposition of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-Pentachlorodibenzofuran, and 2,2',4,4',5,5'-Hexachlorobiphenyl in CYP1A2 Knockout and Parental (C57BL/6N and 129/Sv) Strains of Mice

By Diliberto J.J.   Burgin D.E.   Birnbaum L.S.  

Toxicology and Applied Pharmacology, Vol. 159, Iss. 1, 1999-08 ,pp. : 52-64

Elsevier

Access to resources Recommend Favorite

Role of Altered Arachidonic Acid Metabolism in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Immune Suppression in C57Bl/6 Mice

By Lawrence B.P.   Kerkvliet N.I.  

Toxicological Sciences, Vol. 42, Iss. 1, 1998-03 ,pp. : 13-22

Oxford University Press

Access to resources Recommend Favorite

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of fat cell differentiation

By Brodie A.E.   Azarenko V.A.   C. Y.H.  

Toxicology Letters, Vol. 84, Iss. 1, 1996-01 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on preimplantation mouse embryos

By Wu Q.   Ohsako S.   Baba T.   Miyamoto K.   Tohyama C.  

Toxicology, Vol. 174, Iss. 2, 2002-05 ,pp. : 119-129

Elsevier

Access to resources Recommend Favorite